Alison Bozung
Optometrist · Coral Gables, FLNPI 1114302858
Payments from drug & device makers
Across 65 payments — averaging $307.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dompe US, Inc.$6K
- Alcon$4K
- Alcon Research LLC$3K
- Bausch & Lomb Americas Inc.$2K
- Oyster Point Pharma, Inc.$1K
- Carl Zeiss Meditec USA, Inc.$491
- plus $2K from 10 others
What the payments were for
- Consulting fees$5,41027%
- Speaking & faculty fees$8,97845%
- Travel & lodging$1,7569%
- Food & beverage$3,84119%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dompe US, Inc. | 5 | $6,371 |
| Alcon | 10 | $4,461 |
| Alcon Research LLC | 2 | $3,200 |
| Bausch & Lomb Americas Inc. | 10 | $2,068 |
| Oyster Point Pharma, Inc. | 7 | $1,458 |
| Carl Zeiss Meditec USA, Inc. | 8 | $491 |
| AbbVie(2 entities) | 5 | $482 |
| Sun Pharmaceutical Industries Inc. | 5 | $358 |
| Novartis | 3 | $231 |
| Sight Sciences, Inc. | 1 | $165 |
| Amgen | 2 | $162 |
| Johnson & Johnson Vision Care, Inc. | 1 | $144 |
| Shire North American Group Inc | 3 | $140 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $125 |
| Tarsus Pharmaceuticals, Inc. | 1 | $91 |
| Mallinckrodt Hospital Products Inc. | 1 | $37 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,984 in reported general payments places this provider in the 95th percentile of 3,166 optometrist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 17 | $1,294 |
| Prednisolone Acetate | 15 | $583 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 43 | $522 |
| Latanoprost | 70 | $449 |
| MoxifloxacinMoxifloxacin Hcl | 15 | $322 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 24 | $287 |
| Timolol Maleate | 21 | $188 |
| ErythromycinErythromycin Base | 12 | $114 |
| Brimonidine Tartrate | 23 | $99 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Coral Gables
- Michael KynnJacksonville$4.5M
- Christine HalodaJacksonville$3.1M
- Bradley GieddWinter Park$2.5M
- Christopher PearsonLongwood$2.5M
- Mark PerryOrlando$1.6M
- Bryan StamJacksonville Beach$1M
- Oksana SovaJacksonville$841K
- James HoffmanOrange Park$795K
- April JasperWest Palm Beach$781K
- Jerry RobbenSt Augustine$663K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.